HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
PensionPosition in URGN — UroGen Pharma Ltd.
CIK 1535845
TORONTO, A6
Position in URGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,959,590
-$19,390,252 QoQ
Shares Held
387,074
-65.6% QoQ
Ownership
0.794%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND holds $487,645,247 across 33 Biotechnology names. URGN ranks #21 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75,462 | $58,304,959 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,643,352 | $52,682,869 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
924,562 | $48,742,908 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,202,100 | $48,360,483 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,251 | $48,338,401 | |
| 6 | INCY |
Incyte Corp
|
297,504 | $28,001,076 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
467,800 | $22,547,960 | |
| 8 | EXEL |
Exelixis, Inc.
|
438,000 | $18,785,820 |
All Filings in URGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,959,590 | 387,074 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,349,842 | 1,125,100 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||